Table 1.
Distribution of PELP1 staining and clinical-pathological factors in invasive breast cancer
| Patient number | PELP1 staining |
P | |||
|---|---|---|---|---|---|
| 0–1 | 2 | 3 | |||
| Age | |||||
| <50 | 52 | 4 (7) | 10 (20) | 38 (78) | 0.068 |
| >50 | 107 | 7 (7) | 33 (31) | 67 (62) | |
| Stage | |||||
| T1 (<20 mm) | 88 | 6 (7) | 23 (26) | 59 (67) | 0.983 |
| T2 (20–50 mm) | 71 | 5 (7) | 18 (25) | 48 (68) | |
| Grade | |||||
| 1 | 33 | 0 (0) | 16 (48) | 17 (52) | 0.0005 |
| 2 | 102 | 7 (6) | 24 (24) | 71 (70) | |
| 3 | 24 | 3 (12) | 6 (25) | 15 (63) | |
| Case type | |||||
| Node negative | 52 | 6 (11) | 19 (37) | 27 (52) | 0.003 |
| Node positive | 54 | 2 (4) | 10 (18) | 42 (78) | |
| Metastatic | 53 | 3 (6) | 16 (30) | 34 (64) | |
| ER | |||||
| Positive | 105 | 8 (7) | 32 (31) | 65 (62) | 0.265 |
| Negative (unknown = 4) | 50 | 3 (6) | 11 (22) | 36 (72) | |
| PR | |||||
| Positive | 57 | 8 (7) | 17 (30) | 32 (56) | 0.160 |
| Negative (unknown = 3) | 99 | 3 (3) | 25 (25) | 71 (72) | |